Safety and Efficacy Study of Carvedilol to Treat Children With Congestive Heart Failure

PHASE3CompletedINTERVENTIONAL
Enrollment

161

Participants

Timeline

Start Date

May 31, 2000

Primary Completion Date

June 30, 2005

Study Completion Date

July 31, 2006

Conditions
Congestive Heart Failure
Interventions
DRUG

carvedilol

low-dose carvedilol administered twice daily for 8 months

DRUG

placebo

administered twice daily for 8 months

DRUG

carvedilol

high-dose carvedilol administered twice daily for 8 months

Trial Locations (21)

10016

NYU Medical Center, New York

15213

Children's Hospital of Pittsburgh, Pittsburgh

19104

Children's Hospital of Philadelphia, Philadelphia

33101

University of Miami, Miami

33701

University of Southern Florida, St. Petersburg

37332

Vanderbilt Children's Hospital, Nashville

48109

C.S. Mott Children's Hospital, Ann Arbor

60614

Children's Memorial Hospital, Chicago

77030

Texas Children's Hospital, Houston

80218

University of Colorado, Denver

84132

University of Utah, Salt Lake City

90025

Mattel Children's Hospital at UCLA, Los Angeles

90027

Children's Hospital Los Angeles, Los Angeles

94303

Stanford University, Palo Alto

98105

Seattle Childrens Hospital and Regional Medical Center, Seattle

35249-6852

University of Alabama, Birmingham

02115

Children's Hospital, Boston, Boston

48201-2196

Children's Hospital of Michigan, Detroit

63110-1014

Washington University, St Louis

10032-1537

Columbia University, New York

75235-7794

UT Southwestern Medical Center, Dallas

All Listed Sponsors
collaborator

University of Utah

OTHER

lead

Shaddy, Robert, M.D.

INDIV

NCT00052026 - Safety and Efficacy Study of Carvedilol to Treat Children With Congestive Heart Failure | Biotech Hunter | Biotech Hunter